These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 602945)

  • 21. Platelet phospholipids in thrombocytosis due to myeloproliferative disorders.
    Breuer JH; Harsányi V; Solti V; Hollán SR
    Haemostasis; 1981; 10(3):134-40. PubMed ID: 7262643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal platelet function in myeloproliferative disorders.
    Waddell CC; Brown JA; Repinecz YA
    Arch Pathol Lab Med; 1981 Aug; 105(8):432-5. PubMed ID: 6894852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo platelet release in myeloproliferative disorders.
    Ireland H; Lane DA; Wolff S; Foadi M
    Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inherited abnormalities of platelet glycoproteins.
    Caen JP; Nurden AT; Kunicki TJ
    Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):281-90. PubMed ID: 6117891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].
    Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J
    Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased platelet CD36 constitutes a common marker in myeloproliferative disorders.
    Thibert V; Bellucci S; Cristofari M; Gluckman E; Legrand C
    Br J Haematol; 1995 Nov; 91(3):618-24. PubMed ID: 8555064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.
    George JN; Pickett EB; Saucerman S; McEver RP; Kunicki TJ; Kieffer N; Newman PJ
    J Clin Invest; 1986 Aug; 78(2):340-8. PubMed ID: 2942561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The platelet defect in myeloproliferative disorder (author's transl)].
    Delobel J
    Nouv Rev Fr Hematol (1978); 1976; 16(3):443-6. PubMed ID: 1012918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E
    Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
    Emiliani C; Ciferri S; Mencarelli S; Mezzasoma AM; Momi S; Orlacchio A; Gresele P
    Platelets; 2006 Feb; 17(1):20-9. PubMed ID: 16308183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y
    Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelet function after busulphan in chronic myeloproliferative disorders.
    Barbui T; Bassan R; Viero P; Cortelazzo S; Dini E
    Haematologica; 1983; 68(4):469-77. PubMed ID: 6414897
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders.
    Jensen MK; de Nully Brown P; Lund BV; Nielsen OJ; Hasselbalch HC
    Br J Haematol; 2000 Jul; 110(1):116-24. PubMed ID: 10930987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agglutination activity associated with a glycoprotein extract of human platelet plasma membranes: possible involvement in platelet aggregation.
    Bowles DJ; Rotman A
    FEBS Lett; 1978 Jun; 90(2):283-5. PubMed ID: 668892
    [No Abstract]   [Full Text] [Related]  

  • 35. [Membrane glycoprotein, glycocalicin, of human blood platelets].
    Okumura T
    Rinsho Byori; 1979; Suppl 40():231-43. PubMed ID: 551227
    [No Abstract]   [Full Text] [Related]  

  • 36. A rapid method for assessing megathrombocytes: its application to thrombocytotic and acquired thrombocytopenic states.
    Hunt FA
    Pathology; 1976 Jan; 8(1):47-55. PubMed ID: 987570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic myeloproliferative disorders: a quantitative assessment of platelet ultrastructure.
    Boughton BJ; Jerrome DW; Rychetnik M
    Acta Haematol; 1980; 64(6):319. PubMed ID: 6782797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced amounts of platelet 5-hydroxytryptamine in myeloproliferative disorders.
    Okamoto S; Nishimura J; Motomura S; Ibayashi H
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):142-5. PubMed ID: 7113610
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of surface glycoproteins in human platelet function.
    Nurden AT; Caen JP
    Thromb Haemost; 1976 Feb; 35(1):139-50. PubMed ID: 989185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.